NO20006451L - Inhibitorer av transkripsjonsfaktor NF-kB - Google Patents
Inhibitorer av transkripsjonsfaktor NF-kBInfo
- Publication number
- NO20006451L NO20006451L NO20006451A NO20006451A NO20006451L NO 20006451 L NO20006451 L NO 20006451L NO 20006451 A NO20006451 A NO 20006451A NO 20006451 A NO20006451 A NO 20006451A NO 20006451 L NO20006451 L NO 20006451L
- Authority
- NO
- Norway
- Prior art keywords
- present
- disease
- transcription factor
- inhibitors
- activation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8982798P | 1998-06-19 | 1998-06-19 | |
PCT/US1999/013652 WO1999065449A2 (en) | 1998-06-19 | 1999-06-18 | INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20006451D0 NO20006451D0 (no) | 2000-12-18 |
NO20006451L true NO20006451L (no) | 2000-12-18 |
Family
ID=22219773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20006451A NO20006451L (no) | 1998-06-19 | 2000-12-18 | Inhibitorer av transkripsjonsfaktor NF-kB |
Country Status (21)
Country | Link |
---|---|
US (3) | US6492425B1 (xx) |
EP (1) | EP1085848B1 (xx) |
JP (1) | JP2002518307A (xx) |
KR (1) | KR20010052991A (xx) |
CN (1) | CN1311629A (xx) |
AR (1) | AR019692A1 (xx) |
AT (1) | ATE383769T1 (xx) |
AU (1) | AU4690099A (xx) |
BR (1) | BR9911152A (xx) |
CA (1) | CA2335294A1 (xx) |
CO (1) | CO5021213A1 (xx) |
CZ (1) | CZ20004761A3 (xx) |
DE (1) | DE69937997T2 (xx) |
ES (1) | ES2299251T3 (xx) |
HU (1) | HUP0102782A3 (xx) |
IL (1) | IL140328A0 (xx) |
NO (1) | NO20006451L (xx) |
PL (1) | PL348969A1 (xx) |
TR (1) | TR200003781T2 (xx) |
WO (1) | WO1999065449A2 (xx) |
ZA (1) | ZA200007447B (xx) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69738841D1 (de) | 1996-12-23 | 2008-08-28 | Immunex Corp | Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie |
US6316408B1 (en) | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
EP2009025B1 (en) | 1998-05-14 | 2011-07-27 | Immunex Corporation | Method of inhibiting osteoclast activity |
GB9930616D0 (en) * | 1999-12-24 | 2000-02-16 | Mathilda & Terence Kennedy Ins | Activation and inhibition of the immune system |
EP1134221A1 (en) * | 2000-03-15 | 2001-09-19 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines as lkB kinase inhibitors |
FR2813315B1 (fr) * | 2000-08-23 | 2002-10-18 | Genfit S A | Procede d'identification de substances utiles pour le traitement de l'inflammation mettant en oeuvre l'element de reponse du recepteur ror du gene ikbalpha |
EP1352650B1 (en) * | 2000-12-18 | 2012-03-07 | Institute of Medicinal Molecular Design, Inc. | Inhibitors against the production and release of inflammatory cytokines |
DE60217532T8 (de) | 2001-11-07 | 2008-02-07 | Millennium Pharmaceuticals, Inc., Cambridge | Carboline derivate als ikb-inhibitoren zur behandlung des m ultiplen myelomas |
US7119120B2 (en) | 2001-12-26 | 2006-10-10 | Genzyme Corporation | Phosphate transport inhibitors |
EP1510210A4 (en) * | 2002-06-05 | 2009-01-07 | Inst Med Molecular Design Inc | IMMUNITY-CONTAINING PROTEIN KINASE HEMMER |
EA008769B1 (ru) * | 2002-06-05 | 2007-08-31 | Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. | Лекарственное средство для лечения диабета |
EP1514544A4 (en) * | 2002-06-06 | 2009-01-07 | Inst Med Molecular Design Inc | HYPO-ALLERGENIC |
JP4743382B2 (ja) * | 2002-06-06 | 2011-08-10 | 株式会社医薬分子設計研究所 | O−置換ヒドロキシアリール誘導体 |
CN100506221C (zh) * | 2002-06-10 | 2009-07-01 | 株式会社医药分子设计研究所 | 癌症治疗药 |
EA010470B1 (ru) * | 2002-06-10 | 2008-08-29 | Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. | ИНГИБИТОРЫ АКТИВАЦИИ NF-kB |
TWI280127B (en) * | 2002-06-11 | 2007-05-01 | Inst Med Molecular Design Inc | Remedies for neurodegenerative diseases |
US7324455B2 (en) | 2003-03-14 | 2008-01-29 | International Business Machines Corporation | Transfer of error-analysis and statistical data in a fibre channel input/output system |
US20050256132A1 (en) * | 2003-04-30 | 2005-11-17 | Wyeth | Use of ER selective NF-kB inhibitors for the treatment of sepsis |
US20050004164A1 (en) * | 2003-04-30 | 2005-01-06 | Caggiano Thomas J. | 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
WO2004098510A2 (en) * | 2003-04-30 | 2004-11-18 | Beth Israel Deaconess Medical Center | Cystic fibrosis therapy |
US7981915B2 (en) * | 2003-04-30 | 2011-07-19 | Beth Israel Deaconess Medical Center | Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene |
DE602004030689D1 (de) * | 2003-07-23 | 2011-02-03 | Synta Pharmaceuticals Corp | Verbindungen gegen entzündungen und immun-relevante verwendungen |
US7425580B2 (en) | 2004-05-19 | 2008-09-16 | Wyeth | (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands |
US20080207673A1 (en) * | 2005-05-04 | 2008-08-28 | Michel Xilinas | Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins |
CN100418532C (zh) * | 2005-06-17 | 2008-09-17 | 吕志民 | 治疗多种疾病的NF-κB化合物抑制剂 |
US7671058B2 (en) * | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
EP2201946A4 (en) | 2007-10-23 | 2012-01-25 | Inst Med Molecular Design Inc | HAMMER OF PAI-1 PRODUCTION |
JP2011500853A (ja) * | 2007-10-25 | 2011-01-06 | ファィトシューティカ, インコーポレイテッド | 炎症性腸疾患および/または過敏性腸管症候群に対する処置としてのphy906の使用 |
EP2242367A4 (en) * | 2008-01-08 | 2012-07-04 | Univ Pennsylvania | REL INHIBITORS AND METHODS OF USE |
US20090264514A1 (en) * | 2008-04-18 | 2009-10-22 | The Research Foundation Of State University Of New York | SPHINGOMYELIN SYNTHASE 2 (SMS2) DEFICIENCY ATTENUATES NFkB ACTIVATION, A POTENTIAL ANTI-ATHEROGENIC PROPERTY |
US10640457B2 (en) | 2009-12-10 | 2020-05-05 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and uses thereof |
JP6616057B2 (ja) * | 2010-12-22 | 2019-12-04 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | ヒストンアセチル基転移酵素モジュレーターおよびその使用 |
TWI492920B (zh) * | 2012-04-18 | 2015-07-21 | Nat Defense Medical Ct | 水楊酸苯胺衍生小分子之醫藥組合物及其製備與醫藥用途 |
US9562002B2 (en) | 2013-01-15 | 2017-02-07 | Board Of Regents, The University Of Texas System | STAT3 inhibitor |
CN106659909B (zh) | 2013-08-21 | 2022-01-11 | 德克萨斯州大学***董事会 | 用于靶向连接蛋白半通道的组合物和方法 |
JP2017511340A (ja) | 2014-03-31 | 2017-04-20 | ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | ヒストンアセチルトランスフェラーゼ活性剤及びその使用 |
ES2970434T3 (es) | 2014-09-12 | 2024-05-28 | Union Therapeutics As | Uso antibacteriano de salicilanilidas halogenadas |
CN105797154B (zh) * | 2014-12-31 | 2020-03-10 | 中国科学院上海生命科学研究院 | 软骨干细胞的分离及其应用 |
GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
WO2017122209A2 (en) * | 2016-01-12 | 2017-07-20 | Yeda Research And Development Co. Ltd. | NF-kappaB INHIBITORS |
EP3419998A4 (en) | 2016-02-26 | 2019-09-25 | The Board of Regents of The University of Texas System | CONNEXIN (CX) 43 HEMICANAL BINDING ANTIBODIES AND USES THEREOF |
GB201604484D0 (en) * | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
CA3057284A1 (en) * | 2017-03-21 | 2018-09-27 | Novalead Pharma Inc. | Therapeutic agent for phosphodiesterase inhibition and its related disorders |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
CN114727975A (zh) * | 2019-11-18 | 2022-07-08 | 加利福尼亚大学董事会 | 双雄激素受体/akr1c3抑制剂 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1079177A (en) * | 1963-06-11 | 1967-08-16 | Stecker Internat S P A | Improvements in pesticide composition for destroying internal worm parasites in animals |
GB1079178A (en) * | 1966-07-27 | 1967-08-16 | Stecker Internat S P A | Improvements in pesticide compositions for destroying internal worm parasites in animals |
US4742083A (en) * | 1983-08-24 | 1988-05-03 | Lever Brothers Company | Method of relieving pain and inflammatory conditions employing substituted salicylamides |
US4803279A (en) * | 1985-05-23 | 1989-02-07 | Smithkline Beckman Corporation | 1.4-dihydro-4-pyridyl-substituted imidazo (2,1-b) thiazoles and the corresponding thiazines. |
ATE120753T1 (de) | 1990-08-21 | 1995-04-15 | Upjohn Co | Bisphosphonsäurederivate als antiarthritische mittel. |
AU2140592A (en) * | 1991-05-17 | 1992-12-30 | Chiron Corporation | Inhibitor of nf-kappa b transcriptional activator and uses thereof |
US5466715A (en) * | 1991-12-31 | 1995-11-14 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
DE4200534A1 (de) * | 1992-01-11 | 1993-07-15 | Henkel Kgaa | Neue n-benzyl-4-aminophenole und deren verwendung als entwicklerkomponente in oxidationshaarfaerbemitteln |
ZA944191B (en) * | 1993-06-15 | 1995-02-08 | Univ Australian | Synergistic anthelmintic compositions |
CA2298824A1 (en) * | 1997-08-06 | 1999-02-18 | Smithkline Beecham Corporation | Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases |
-
1998
- 1998-06-19 HU HU0102782A patent/HUP0102782A3/hu unknown
-
1999
- 1999-06-18 KR KR1020007014386A patent/KR20010052991A/ko not_active Application Discontinuation
- 1999-06-18 CN CN99807571A patent/CN1311629A/zh active Pending
- 1999-06-18 JP JP2000554329A patent/JP2002518307A/ja not_active Withdrawn
- 1999-06-18 AU AU46900/99A patent/AU4690099A/en not_active Abandoned
- 1999-06-18 ES ES99930345T patent/ES2299251T3/es not_active Expired - Lifetime
- 1999-06-18 AT AT99930345T patent/ATE383769T1/de not_active IP Right Cessation
- 1999-06-18 DE DE69937997T patent/DE69937997T2/de not_active Expired - Fee Related
- 1999-06-18 TR TR2000/03781T patent/TR200003781T2/xx unknown
- 1999-06-18 IL IL14032899A patent/IL140328A0/xx unknown
- 1999-06-18 WO PCT/US1999/013652 patent/WO1999065449A2/en active IP Right Grant
- 1999-06-18 CZ CZ20004761A patent/CZ20004761A3/cs unknown
- 1999-06-18 PL PL99348969A patent/PL348969A1/xx unknown
- 1999-06-18 BR BR9911152-7A patent/BR9911152A/pt not_active Application Discontinuation
- 1999-06-18 CO CO99038264A patent/CO5021213A1/es unknown
- 1999-06-18 AR ARP990102955A patent/AR019692A1/es unknown
- 1999-06-18 CA CA002335294A patent/CA2335294A1/en not_active Abandoned
- 1999-06-18 US US09/720,018 patent/US6492425B1/en not_active Expired - Fee Related
- 1999-06-18 EP EP99930345A patent/EP1085848B1/en not_active Expired - Lifetime
-
2000
- 2000-12-13 ZA ZA200007447A patent/ZA200007447B/en unknown
- 2000-12-18 NO NO20006451A patent/NO20006451L/no not_active Application Discontinuation
-
2002
- 2002-07-31 US US10/210,560 patent/US20030092771A1/en not_active Abandoned
-
2005
- 2005-10-03 US US11/242,572 patent/US20060035979A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4690099A (en) | 2000-01-05 |
TR200003781T2 (tr) | 2001-07-23 |
JP2002518307A (ja) | 2002-06-25 |
US20060035979A1 (en) | 2006-02-16 |
IL140328A0 (en) | 2002-02-10 |
PL348969A1 (en) | 2002-06-17 |
US20030092771A1 (en) | 2003-05-15 |
EP1085848A4 (en) | 2004-09-08 |
EP1085848A2 (en) | 2001-03-28 |
DE69937997T2 (de) | 2009-02-19 |
HUP0102782A3 (en) | 2002-12-28 |
NO20006451D0 (no) | 2000-12-18 |
ES2299251T3 (es) | 2008-05-16 |
CA2335294A1 (en) | 1999-12-23 |
AR019692A1 (es) | 2002-03-13 |
CO5021213A1 (es) | 2001-03-27 |
HUP0102782A2 (hu) | 2001-12-28 |
KR20010052991A (ko) | 2001-06-25 |
DE69937997D1 (xx) | 2008-03-06 |
US6492425B1 (en) | 2002-12-10 |
CZ20004761A3 (cs) | 2001-08-15 |
EP1085848B1 (en) | 2008-01-16 |
WO1999065449A3 (en) | 2000-03-30 |
ZA200007447B (en) | 2002-02-13 |
ATE383769T1 (de) | 2008-02-15 |
CN1311629A (zh) | 2001-09-05 |
BR9911152A (pt) | 2001-03-06 |
WO1999065449A2 (en) | 1999-12-23 |
WO1999065449A8 (en) | 2001-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20006451L (no) | Inhibitorer av transkripsjonsfaktor NF-kB | |
NO995543D0 (no) | Monoestere fra probucol for behandling av kardiovaskulaer og inflammatorisk sykdom | |
CY1108301T1 (el) | Συνθεση περιλαμβανουσα αναστολεα αποακετυλασης ιστονης εμφανιζουσα διφασικη απελευθερωση | |
MXPA06000326A (es) | Novedosos compuestos y composiciones que contienen esteroles y/o estanoles e inhibidores de biosintesis de colesterol, y su uso en el tratamiento o prevencion de una variedad de enfermedades y condiciones. | |
MXPA01007335A (es) | Derivados de acilo los cuales tratan trastornos relacionados con alfa4 beta1 integrina y cd49d/cd29 (vla-4). | |
TW200505449A (en) | Pharmaceutical compositions and dosage forms of thalidomide | |
DK1509232T3 (da) | Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom | |
YU64100A (sh) | Postupak za sintetizovanje cox-2 inhibitora | |
WO1997018207A3 (en) | Novel macrocyclic compounds as metalloprotease inhibitors | |
ATE256672T1 (de) | 4,5-diaryl-3(2h)-furanon derivate als cyclooxygenase-2 inhibitoren | |
NO20006452L (no) | Inhibitorer av transkripsjonsfaktor NF-kB | |
WO2001096298A3 (en) | 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase | |
AU2002363182A1 (en) | Smad7 inhibitors for the treatment of cns diseases | |
NO20045234L (no) | 2,6-kinolinyl- og 2,6-naftylderivater, fremgangsmate for fremstilling av disse, og anvendelse av disse som VLA-4-inhibitorer | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
DE60233261D1 (de) | Inhibitoren von humanem adam-10 | |
HUP0402577A2 (hu) | Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra | |
MY133512A (en) | Non-steroidal il-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors | |
NO20053341L (no) | Hindring og behandling av Alzheimers sykdom. | |
BR0008437A (pt) | Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos | |
MY131170A (en) | Therapeutic agent for glomerular disease | |
DE69810100D1 (de) | Macrocyclische verbindungen als metallproteaseinhibitoren | |
Shanmugavani et al. | Computational approaches for screening for bacterial inhibitors from the plant Malabar nut | |
GB0113663D0 (en) | Use of organic compounds | |
DK0752990T3 (da) | Benzisothiazolderivater som inhibitorer af 5-lipoxygenasebiosyntese |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |